Thanks for visiting! Welcome to a new way to research case law. You are viewing a free summary from Descrybe.ai. For citation and good law / bad law checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.
Integra Lifesciences I, Ltd. v. Merck KGaA
Citations: 421 F.3d 1289; 2005 WL 1965928Docket: Nos. 02-1052, 02-1065
Court: Court of Appeals for the Federal Circuit; August 17, 2005; Federal Appellate Court
The court has received a certified copy of the judgment from the Supreme Court of the United States regarding Merck KGaA v. Integra Lifesciences I, Ltd. The Supreme Court vacated the previous judgment of this court and remanded the case for further proceedings aligned with its opinion. The order includes the following directives: 1. The mandate is recalled, and the appeal is reinstated. 2. The case is returned to the original merits panel. 3. New briefs must be filed, specifically addressing the Supreme Court's decision. 4. The appellants' principal brief is due within 60 days from the date of this order, with subsequent briefs following the schedule outlined in Fed. Cir. R. 31(a). 5. An original and 22 copies of all briefs must be submitted, along with two copies served to opposing counsel. 6. The court has sua sponte permitted the filing of amicus briefs.